GE Ventures and Mayo Clinic have created a new joint venture (JV) company called Vitruvian Networks, Inc., which will expedite the treatment of cancer and other diseases by providing therapy producers in these areas with modern software systems and manufacturing services.
Vitruvian Networks will use Mayo Clinic’s data related to biomarkers, cell therapy processes and leverage GE Healthcare’s cell therapy business tools to develop personalised therapies.
Shanghai Fosun Pharma has announced new fund raising plan for replenishing its working capital and pay off existing loans.
The company will raise approximately $928m through placement of renewable corporate bonds to qualified private investors.
Cambrooke Therapeutics has completed a series C financing round for its global expansion and entry into other disease states.
The deal was led by Seventure Partners and also included Galen Partners and co-investors from Europe and the US.
Image: GE Ventures and Mayo Clinic have created a new joint venture (JV) company called Vitruvian Networks: Photo: Courtesy:Micheal Hicks